Cargando…

Tumor microenvironment in giant cell tumor of bone: evaluation of PD-L1 expression and SIRPα infiltration after denosumab treatment

Giant cell tumor of bone (GCTB) is an intermediate malignant bone tumor that is locally aggressive and rarely metastasizes. Denosumab, which is a receptor activator of nuclear factor kappa B ligand (RANKL) inhibitor, can be used to treat GCTB. We focused on potential immunotherapy for GCTB and inves...

Descripción completa

Detalles Bibliográficos
Autores principales:	Toda, Yu, Kohashi, Kenichi, Yamamoto, Hidetaka, Ishihara, Shin, Ito, Yoshihiro, Susuki, Yosuke, Kawaguchi, Kengo, Kiyozawa, Daisuke, Takamatsu, Dai, Kinoshita, Izumi, Yamada, Yuichi, Maehara, Junki, Kimura, Atsushi, Tamiya, Sadafumi, Taguchi, Kenichi, Matsunobu, Tomoya, Matsumoto, Yoshihiro, Nakashima, Yasuharu, Mawatari, Masaaki, Oda, Yoshinao
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group UK 2021
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8292371/ https://www.ncbi.nlm.nih.gov/pubmed/34285260 http://dx.doi.org/10.1038/s41598-021-94022-w

Ejemplares similares

Prognostic value of nuclear morphometry in myxoid liposarcoma
por: Kawaguchi, Kengo, et al.
Publicado: (2023)

Clinical, Radiological, and Histopathological Characteristics of Periosteal Chondrosarcoma with a Focus on the Frequency of Medullary Invasion
por: Nakagawa, Makoto, et al.
Publicado: (2022)

Oncogenic roles of SMARCB1/INI1 and its deficient tumors
por: Kohashi, Kenichi, et al.
Publicado: (2017)

Aggressive Angiomyxoma of the Pelvis with a Cellular Nodule Composed of Tumor Cells showing Epithelioid Features
por: Tajima, Shogo, et al.
Publicado: (2014)

Nuclear β-catenin translocation plays a key role in osteoblast differentiation of giant cell tumor of bone
por: Kimura, Atsushi, et al.
Publicado: (2022)

The Expression of Insulin-Like Growth Factor II Messenger RNA-Binding Protein 3 Upregulated in Intradural Extramedullary Schwannomas
por: Bekki, Hirofumi, et al.
Publicado: (2022)

Risk Factors of Periprosthetic Infection in Patients with Tumor Prostheses Following Resection for Musculoskeletal Tumor of the Lower Limb
por: Fujiwara, Toshifumi, et al.
Publicado: (2020)

IL‐34 in hepatoblastoma cells potentially promote tumor progression via autocrine and paracrine mechanisms
por: Irie, Tomoaki, et al.
Publicado: (2022)

Clinicopathological Significance and Antitumor Effect of MPHOSPH1 in Testicular Germ Cell Tumor
por: Abe, Tatsuro, et al.
Publicado: (2018)

Malignant transformation of phosphaturic mesenchymal tumor: a case report and literature review
por: Oyama, Noriko, et al.
Publicado: (2020)

Perivascular epithelial cell tumor (PEComa) of the pancreas: a case report and review of previous literatures
por: Mizuuchi, Yusuke, et al.
Publicado: (2016)

Bone and soft tissue tumors presenting as sciatic notch dumbbell masses: A critical differential diagnosis of sciatica
por: Matsumoto, Yoshihiro, et al.
Publicado: (2016)

Expression of Forkhead box M1 in soft tissue leiomyosarcoma: Clinicopathologic and in vitro study using a newly established cell line
por: Maekawa, Akira, et al.
Publicado: (2016)

Insights into CD47/SIRPα axis-targeting tumor immunotherapy
por: Zhang, Xuyao, et al.
Publicado: (2018)

Giant Cell Tumor of Bone of the First Rib Successfully Treated with Combined Preoperative Denosumab Therapy and Surgery via a Transmanubrial Approach
por: Matsunobu, Tomoya, et al.
Publicado: (2021)

Hypoxia-inducible factor 1 alpha is a poor prognostic factor and potential therapeutic target in malignant peripheral nerve sheath tumor
por: Fukushima, Suguru, et al.
Publicado: (2017)

Correction: Hypoxia-inducible factor 1 alpha is a poor prognostic factor and potential therapeutic target in malignant peripheral nerve sheath tumor
por: Fukushima, Suguru, et al.
Publicado: (2018)

Spontaneous Regression of Metachronous Intra-Abdominal Desmoid Tumor in a Patient with Familial Adenomatous Polyposis
por: Tsuchihashi, Kenji, et al.
Publicado: (2022)

Does the Use of Peripheral Immune-Related Markers Indicate Whether to Administer Pazopanib, Trabectedin, or Eribulin to Advanced Soft Tissue Sarcoma Patients?
por: Shimada, Eijiro, et al.
Publicado: (2021)

Advances in Anti-Tumor Treatments Targeting the CD47/SIRPα Axis
por: Zhang, Wenting, et al.
Publicado: (2020)

Concerted BAG3 and SIRPα blockade impairs pancreatic tumor growth
por: De Marco, Margot, et al.
Publicado: (2022)

Solid‐type poorly differentiated adenocarcinoma of the stomach: Deficiency of mismatch repair and SWI/SNF complex
por: Tsuruta, Shinichi, et al.
Publicado: (2020)

BYON4228 is a pan-allelic antagonistic SIRPα antibody that potentiates destruction of antibody-opsonized tumor cells and lacks binding to SIRPγ on T cells
por: van Helden, Mary J, et al.
Publicado: (2023)

Cancer‐testis antigens PRAME and NY‐ESO‐1 correlate with tumour grade and poor prognosis in myxoid liposarcoma
por: Iura, Kunio, et al.
Publicado: (2015)

Dedifferentiated chondrosarcoma of the cervical spine: a case report
por: Matsumoto, Yoshihiro, et al.
Publicado: (2013)

Solitary fibrous tumor in the liver: case report and literature review
por: Yugawa, Kyohei, et al.
Publicado: (2019)

Targeting SIRPα in cancer
por: Ho, Jenny M., et al.
Publicado: (2013)

Association between peripheral blood markers and immune-related factors on tumor cells in patients with resected primary lung adenocarcinoma
por: Takada, Kazuki, et al.
Publicado: (2019)

Elevated expression of HSP90 and the antitumor effect of an HSP90 inhibitor via inactivation of the Akt/mTOR pathway in undifferentiated pleomorphic sarcoma
por: Bekki, Hirofumi, et al.
Publicado: (2015)

The disbalance of LRP1 and SIRPα by psychological stress dampens the clearance of tumor cells by macrophages
por: Wu, Yanping, et al.
Publicado: (2022)

SIRPα and PD1 expression on tumor-associated macrophage predict prognosis of intrahepatic cholangiocarcinoma
por: Yang, Hui, et al.
Publicado: (2022)

Shape Factor of the Spinal Cord: A Possible Predictor of Surgical Outcome for Intradural Extramedullary Spinal Tumors in the Thoracic Spine
por: Matsumoto, Yoshihiro, et al.
Publicado: (2021)

Anticancer efficacy of monotherapy with antibodies to SIRPα/SIRPβ1 mediated by induction of antitumorigenic macrophages
por: Sakamoto, Mariko, et al.
Publicado: (2021)

Successful chemotherapeutic treatment for metastatic littoral cell angioma: A case report
por: Takayoshi, Kotoe, et al.
Publicado: (2018)

Spondylectomy for Giant Cell Tumor After Denosumab Therapy
por: de Carvalho Cavalcante, Rodrigo Alves, et al.
Publicado: (2016)

A case of autonomous cortisol secretion in a patient with subclinical Cushing’s syndrome, GNAS mutation, and paradoxical cortisol response to dexamethasone
por: Sakaguchi, Chihiro, et al.
Publicado: (2019)

Therapeutic modulation of the CD47-SIRPα axis in the pediatric tumor microenvironment: working up an appetite
por: Gupta, Ajay, et al.
Publicado: (2020)

Intratumoral SIRPα-deficient macrophages activate tumor antigen-specific cytotoxic T cells under radiotherapy
por: Bian, Zhen, et al.
Publicado: (2021)

Clinical Outcome and Prognostic Factors of Malignant Spinal Dumbbell Tumors
por: Matsumoto, Yoshihiro, et al.
Publicado: (2018)

Metabolic Tumor Volume by (18)F-FDG PET/CT Can Predict the Clinical Outcome of Primary Malignant Spine/Spinal Tumors
por: Matsumoto, Yoshihiro, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_7agie6491ldo29fqltscp80mea